Description of Natural Alternatives International Inc's Business Segments

Our primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the U.S. Our private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct response television and retail stores. We manufacture products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of our customer’s preferences.

We provide strategic partnering services to our private-label contract manufacturing customers, including the following:

customized product formulation;

clinical studies;

manufacturing;

marketing support;

international regulatory and label law compliance;

international product registration; and

packaging in multiple formats and labeling design.

We also seek to commercialize our patent and trademark through direct distribution and sale of CarnoSyn® and SR CarnoSyn®, new contract manufacturing opportunities, and various license and similar arrangements.

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Composition of Natural Alternatives International Inc Revenues by Segments


Private Label Contract Manufacturing	290.19 %	of total Revenue
Patent and Trademark Licensing	15.06 %	of total Revenue

Q3 three months ended (Mar 31 2026)
Revenues by Business Segments	Revenues (in millions $)	% (of total Revenues)
Private Label Contract Manufacturing	102.68	290.19 %
Patent and Trademark Licensing	5.33	15.06 %
Total	35.38	100 %

Q3 three months ended (Mar 31 2026)
Revenue Growth rates by Segment	Y/Y Revenue %	Q/Q Revenue %
Private Label Contract Manufacturing	279.24 %	213 %
Patent and Trademark Licensing	215.14 %	167.65 %
Total	27.16 %	2.59 %

Q3 three months ended (Mar 31 2026)
Income by Business Segments	Income (in millions $)	% (Profit Margin)
Private Label Contract Manufacturing	-0.65	-
Patent and Trademark Licensing	1.83	34.25 %
Total	-4.31	-
Corporate Non Segment	-6.75	-

Q3 three months ended (Mar 31 2026)
Income Growth rates by Segment	Y/Y Income %	Q/Q Income %
Private Label Contract Manufacturing	-	-
Patent and Trademark Licensing	56.52 %	58.97 %
Total	-	-
Corporate Non Segment	-	-

Annual Report on Natural Alternatives International Inc Divisions, Sales by Country


UNITED STATES	61.2 %	of total Revenue
Non-US	39.24 %	of total Revenue

Twelve months ended 2025
NAII s Annual Revenue by Geography and Business Segments	Sales (in millions $)	% (of total Sales)
Total	129.29	100 %
UNITED STATES	79.13	61.2 %
Non-US	50.73	39.24 %

Twelve months ended 2025
NAII s Annual Income by Country and Business Segments	Income (in millions $)	% (Profit Margin)
Total	-13.58	-

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments	% Y/Y Sales Growth	% Y/Y Income Growth
Private Label Contract Manufacturing	-	-
Patent and Trademark Licensing	-	-
Total	13.61 %	-
UNITED STATES	7.64 %	-
Non-US	25.94 %	-

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.